Clinical assessments were conducted every 3 months to evaluate efficacy, measured as percentage of total weight loss (%TWL), excess weight loss (%EWL), changes in BMI, and improvement in comorbidities, as well as tolerance, monitored for adverse effects including gastrointestinal symptoms (e.g., nausea, vomiting, diarrhea) and discontinuation rates
Mitochondrial dysfunctions in patients with migraine
Kim tra ngun gc xut x: Bn nn ch n ngun gc xut x ca cc sn phm Glutathione trn th trng
Syftet r att minska utslppen som ktt- och brnsleproduktionen medfr
Exposure to radon and ambient particle radioactivity during pregnancy and adverse maternal, fetal and perinatal outcomes: the current literature and potential mechanisms